Resources from the same session
70MO - Genomic profiling to expand precision cancer medicine in the real world: The ROME trial
Presenter: Andrea Botticelli
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Abstract
Slides
Webcast
28MO - Adapting the Time-to-Event Continual Reassessment Method (TiTE-CRM) to include consolidation immunotherapy in a phase I drug-radiotherapy platform trial
Presenter: Jessica Kendall
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Abstract
Slides
Webcast
79MO - Developing international consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: The DEFINE (DosE FIndiNg Extensions) study
Presenter: Olga Solovyeva
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Abstract
Slides
Webcast
80MO - Optimising participant flow diagrams for phase I clinical trials
Presenter: Emily Alger
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Abstract
Slides
Webcast
Invited Discussant
Presenter: Jordi Rodon
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Slides
Webcast
Oncology phase I trial design and conduct: Time for a change - MDICT Guidelines 2022
Presenter: Lesley Seymour
Session: Mini Oral session: Optimal tools and methods for developing and implementing precision therapeutics
Resources:
Slides
Webcast